Advanced search

Vol 14, No 1 (2021)
Guidelines / Expert consensus
Published online: 2021-10-06

open access

View PDF Download PDF file
Page views 6096
Article views/downloads 630
Get Citation

Connect on Social Media

Connect on Social Media

Polish Society of Nephrology Working Group — management of pregnant women with chronic kidney disease

Magdalena Durlik1, Marcin Adamczak, Ilona Kurnatowska, Tomasz Stompór
Renal Disease and Transplantation Forum 2021;14(1).

Abstract

Not available

Keywords: pregnancychronic kidney diseaseprimary and secondary nephropathyimmunosuppressive drugshypertensionurinary tract infectionsrenal transplantationgenetic disorders of the kidneyacute kidney injury

Article available in PDF format

View PDF Download PDF file

References

  1. Gonzalez Suarez ML, Kattah A, Grande JP, et al. Renal Disorders in Pregnancy: Core Curriculum 2019. Am J Kidney Dis. 2019; 73(1): 119–130.
    CrossRefPubMed
  2. Piccoli GB, Zakharova E, Attini R, et al. Pregnancy in Chronic Kidney Disease: Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Different CKD Stages and Phases. J Clin Med. 2018; 7(11).
    CrossRefPubMed
  3. Wiles KS, Nelson-Piercy C, Bramham K, et al. Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years' experience. BMC Nephrol. 2015; 16(3): 28–184.
    CrossRefPubMed
  4. Piccoli GB, Attini R, Vasario E, et al. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010; 5(5): 844–855.
    CrossRefPubMed
  5. Zhang JJ, Ma XX, Hao Li, et al. A Systematic Review and Meta-Analysis of Outcomes of Pregnancy in CKD and CKD Outcomes in Pregnancy. Clin J Am Soc Nephrol. 2015; 10(11): 1964–1978.
    CrossRefPubMed
  6. Piccoli GB, Cabiddu G, Attini R, et al. Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol. 2015; 26(8): 2011–2022.
    CrossRefPubMed
  7. Gruber MF. Food and Drug Administration, HHS. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule. Fed Regist. 2014; 79(233): 72063–72103.
    PubMed
  8. Ponticelli C, Moroni G. Fetal Toxicity of Immunosuppressive Drugs in Pregnancy. J Clin Med. 2018; 7(12).
    CrossRefPubMed
  9. Immunosuppressants. Reactions Weekly. 2018; 1732(1): 196–196.
    CrossRef
  10. Hebert MF, Zheng S, Hays K, et al. Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation. 2013; 95(7): 908–915.
    CrossRefPubMed
  11. King RW, Baca MJ, Armenti VT, et al. Pregnancy Outcomes Related to Mycophenolate Exposure in Female Kidney Transplant Recipients. Am J Transplant. 2017; 17(1): 151–160.
    CrossRefPubMed
  12. Tykarski A, Filipiak KJ, Januszewicz A, et al. Zasady postępowania w nadciśnieniu tętniczym — 2019 rok. Wytyczne Polskiego Towarzystwa nienia iczego. Nadciś Tętn Prakt. 2019; 5: 1–84.
  13. Prejbisz A, Dobrowolski P, Kosiński P, et al. Management of hypertension in pregnancy: prevention, diagnosis, treatment and long‑term prognosis. Kardiol Pol. 2019; 77(7-8): 757–806.
    CrossRefPubMed
  14. Piccoli GB, Cabiddu G, Attini R, et al. Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question). Curr Hypertens Rep. 2016; 18(5): 35.
    CrossRefPubMed
  15. Hall M. Pregnancy in Women With CKD: A Success Story. Am J Kidney Dis. 2016; 68(4): 633–639.
    CrossRefPubMed
  16. Gonzalez Suarez ML, Kattah A, Grande JP, et al. Renal Disorders in Pregnancy: Core Curriculum 2019. Am J Kidney Dis. 2019; 73(1): 119–130.
    CrossRefPubMed
  17. Krane NK, Hamrahian M. Pregnancy: kidney diseases and hypertension. Am J Kidney Dis. 2007; 49(2): 336–345.
    CrossRefPubMed
  18. Zhang JJ, Ma XX, Hao Li, et al. A Systematic Review and Meta-Analysis of Outcomes of Pregnancy in CKD and CKD Outcomes in Pregnancy. Clin J Am Soc Nephrol. 2015; 10(11): 1964–1978.
    CrossRefPubMed
  19. Bateman BT, Bansil P, Hernandez-Diaz S, et al. Prevalence, trends, and outcomes of chronic hypertension: a nationwide sample of delivery admissions. Am J Obstet Gynecol. 2012; 206(2): 134.e1–134.e8.
    CrossRefPubMed
  20. Coca Payeras A, Williams B, Mancia G, et al. ESC Scientific Document Group . 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104.
    CrossRefPubMed
  21. Bello NA, Miller E, Cleary K, et al. Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period. Curr Hypertens Rep. 2018; 20(12): 101.
    CrossRefPubMed
  22. Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015; 372(5): 407–417.
    CrossRefPubMed
  23. Webster LM, Conti-Ramsden F, Seed PT, et al. Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2017; 6(5).
    CrossRefPubMed
  24. Magee LA, von Dadelszen P, Singer J, et al. CHIPS Study Group*. The CHIPS Randomized Controlled Trial (Control of Hypertension in Pregnancy Study): Is Severe Hypertension Just an Elevated Blood Pressure? Hypertension. 2016; 68(5): 1153–1159.
    CrossRefPubMed
  25. Silversides CK, Grewal J, Mason J, et al. Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001; 104(5): 515–521.
    CrossRefPubMed
  26. Hanson MA, Bardsley A, De-Regil LM, et al. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: "Think Nutrition First". Int J Gynaecol Obstet. 2015; 131 Suppl 4: S213–S253.
    CrossRefPubMed
  27. Cockburn J, Ounsted M, Moar VA, et al. FINAL REPORT OF STUDY ON HYPERTENSION DURING PREGNANCY: THE EFFECTS OF SPECIFIC TREATMENT ON THE GROWTH AND DEVELOPMENT OF THE CHILDREN. The Lancet. 1982; 319(8273): 647–649.
    CrossRef
  28. Hoeltzenbein M, Beck E, Fietz AK, et al. Pregnancy Outcome After First Trimester Use of Methyldopa: A Prospective Cohort Study. Hypertension. 2017; 70(1): 201–208.
    CrossRefPubMed
  29. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 203 Summary: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019; 133(1): 215–219.
    CrossRefPubMed
  30. Clark SM, Dunn HE, Hankins GDV. A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy. Semin Perinatol. 2015; 39(7): 548–555.
    CrossRefPubMed
  31. Kurtzman JL, Thorp JM, Spielman FJ, et al. Do nifedipine and verapamil potentiate the cardiac toxicity of magnesium sulfate? Am J Perinatol. 1993; 10(6): 450–452.
    CrossRefPubMed
  32. Magee LA, von Dadelszen P, Singer J, et al. CHIPS Study Group. Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa? BJOG. 2016; 123(7): 1135–1141.
    CrossRefPubMed
  33. Magee LA, Pels A, Helewa M, et al. SOGC Hypertension Guideline Committee, Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014; 36(5): 416–441.
    CrossRefPubMed
  34. Krane NK, Hamrahian M. Pregnancy: kidney diseases and hypertension. Am J Kidney Dis. 2007; 49(2): 336–345.
    CrossRefPubMed
  35. Piccoli GB, Cabiddu G, Attini R, et al. Risk of Adverse Pregnancy Outcomes in Women with CKD. J Am Soc Nephrol. 2015; 26(8): 2011–2022.
    CrossRefPubMed
  36. Blom K, Odutayo A, Bramham K, et al. Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines. Clin J Am Soc Nephrol. 2017; 12(11): 1862–1872.
    CrossRefPubMed
  37. Wang F, Lu JD, Zhu Y, et al. Renal Outcomes of Pregnant Patients with Immunoglobulin A Nephropathy: A Systematic Review and Meta-Analysis. Am J Nephrol. 2019; 49(3): 214–224.
    CrossRefPubMed
  38. Gonzalez Suarez ML, Kattah A, Grande JP, et al. Renal Disorders in Pregnancy: Core Curriculum 2019. Am J Kidney Dis. 2019; 73(1): 119–130.
    CrossRefPubMed
  39. Li Y, Wang W, Wang Y, et al. Fetal Risks and Maternal Renal Complications in Pregnancy with Preexisting Chronic Glomerulonephritis. Med Sci Monit. 2018; 24: 1008–1016.
    CrossRefPubMed
  40. De Castro I, Easterling TR, Bansal N, et al. Nephrotic syndrome in pregnancy poses risks with both maternal and fetal complications. Kidney Int. 2017; 91(6): 1464–1472.
    CrossRefPubMed
  41. Oliverio AL, Zee J, Mariani LH, et al. Renal Complications in Pregnancy Preceding Glomerulonephropathy Diagnosis. Kidney Int Rep. 2019; 4(1): 159–162.
    CrossRefPubMed
  42. Hladunewich MA, Bramham K, Jim B, et al. Managing glomerular disease in pregnancy. Nephrol Dial Transplant. 2017; 32(suppl_1): i48–i56.
    CrossRefPubMed
  43. Wiles K, Chappell L, Clark K, et al. Clinical practice guideline on pregnancy and renal disease. BMC Nephrol. 2019; 20(1): 401.
    CrossRefPubMed
  44. Wiles KS, Nelson-Piercy C, Bramham K, et al. Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years' experience. BMC Nephrol. 2015; 16(3): 28–184.
    CrossRefPubMed
  45. Barbour SJ, Greenwald A, Djurdjev O, et al. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int. 2012; 81(2): 190–195.
    CrossRefPubMed
  46. Basude S, Hein C, Curtis SL, et al. Low-molecular-weight heparin or warfarin for anticoagulation in pregnant women with mechanical heart valves: what are the risks? A retrospective observational study. BJOG. 2012; 119(8): 1008–13; discussion 1012.
    CrossRefPubMed
  47. Kamel H, Navi BB, Sriram N, et al. Risk of a thrombotic event after the 6-week postpartum period. N Engl J Med. 2014; 370(14): 1307–1315.
    CrossRefPubMed
  48. Bateman BT, Hernandez-Diaz S, Fischer MA, et al. Statins and congenital malformations: cohort study. BMJ. 2015; 350: h1035.
    CrossRefPubMed
  49. Colla L, Diena D, Rossetti M, et al. Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era. J Nephrol. 2018; 31(3): 361–383.
    CrossRefPubMed
  50. Webster P, Lightstone L, McKay DB, et al. Pregnancy in chronic kidney disease and kidney transplantation. Kidney Int. 2017; 91(5): 1047–1056.
    CrossRefPubMed
  51. Shah S, Verma P. Overview of Pregnancy in Renal Transplant Patients. Int J Nephrol. 2016; 2016: 4539342.
    CrossRefPubMed
  52. Garcia-Donaire JA, Acevedo M, Gutiérrez MJ, et al. Tacrolimus as basic immunosuppression in pregnancy after renal transplantation. A single-center experience. Transplant Proc. 2005; 37(9): 3754–3755.
    CrossRefPubMed
  53. Zheng S, Easterling TR, Umans JG, et al. Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit. 2012; 34(6): 660–670.
    CrossRefPubMed
  54. Vanhove T, Annaert P, Kuypers DRJ. Clinical determinants of calcineurin inhibitor disposition: a mechanistic review. Drug Metab Rev. 2016; 48(1): 88–112.
    CrossRefPubMed
  55. Lu TYT, Ng KP, Cambridge G, et al. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthritis Rheum. 2009; 61(4): 482–487.
    CrossRefPubMed
  56. Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016; 75(5): 795–810.
    CrossRefPubMed
  57. Constantinescu S, Pai A, Coscia L, et al. Breast-feeding after transplantation. Best Practice & Research Clinical Obstetrics & Gynaecology. 2014; 28(8): 1163–1173.
    CrossRef
  58. Bramham K. Diabetic Nephropathy and Pregnancy. Semin Nephrol. 2017; 37(4): 362–369.
    CrossRefPubMed
  59. Ringholm L, Damm JA, Vestgaard M, et al. Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding. Curr Diab Rep. 2016; 16(2): 12.
    CrossRefPubMed
  60. Mathiesen ER, Ringholm L, Feldt-Rasmussen Bo, et al. Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment. Clin J Am Soc Nephrol. 2012; 7(12): 2081–2088.
    CrossRefPubMed
  61. Spotti D. Pregnancy in women with diabetic nephropathy. J Nephrol. 2019; 32(3): 379–388.
    CrossRefPubMed
  62. American Diabetes Association. 14. Management of Diabetes in Pregnancy: . Diabetes Care. 2019; 42(Suppl 1): S165–S172.
    CrossRefPubMed
  63. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę, 2019. Stanowisko Polskiego Towarzystwa ogicznego. Diabetol Prakt. 2019; 5: 1–102.
  64. Zhang JJ, Ma XX, Hao Li, et al. A Systematic Review and Meta-Analysis of Outcomes of Pregnancy in CKD and CKD Outcomes in Pregnancy. Clin J Am Soc Nephrol. 2015; 10(11): 1964–1978.
    CrossRefPubMed
  65. Hanly J. The Nervous System in Systemic Lupus Erythematosus. Systemic Lupus Erythematosus. 2001: 414–428.
    CrossRef
  66. Sammaritano LR, Yelnik CM, Porter TF, et al. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes. Arthritis Rheumatol. 2016; 68(8): 1964–1969.
    CrossRefPubMed
  67. Buyon JP, Kim MY, Guerra MM, et al. Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. Ann Intern Med. 2015; 163(3): 153–163.
    CrossRefPubMed
  68. Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun. 2016; 74: 194–200.
    CrossRefPubMed
  69. Moroni G, Doria A, Giglio E, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun. 2016; 74: 6–12.
    CrossRefPubMed
  70. Andreoli L, Bertsias GK, Agmon-Levin N, et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017; 76(3): 476–485.
    CrossRefPubMed
  71. Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J Nephrol. 2016; 29(3): 277–303.
    CrossRefPubMed
  72. Buyon JP, Kim MY, Guerra MM, et al. Kidney Outcomes and Risk Factors for Nephritis (Flare/) in a Multiethnic Cohort of Pregnant Patients with Lupus. Clin J Am Soc Nephrol. 2017; 12(6): 940–946.
    CrossRefPubMed
  73. Blom K, Odutayo A, Bramham K, et al. Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines. Clin J Am Soc Nephrol. 2017; 12(11): 1862–1872.
    CrossRefPubMed
  74. Soh MC, Nelson-Piercy C, Soh MC, et al. High-risk pregnancy and the rheumatologist. Rheumatology (Oxford). 2015; 54(4): 572–587.
    CrossRefPubMed
  75. Gianfreda D, Quaglini S, Frontini G, et al. Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? J Autoimmun. 2017; 84: 46–54.
    CrossRefPubMed
  76. Machen L, Clowse MEB. Vasculitis and Pregnancy. Rheum Dis Clin North Am. 2017; 43(2): 239–247.
    CrossRefPubMed
  77. Sangle SR, Vounotrypidis P, Briley A, et al. Pregnancy outcome in patients with systemic vasculitis: a single-centre matched case-control study. Rheumatology (Oxford). 2015; 54(9): 1582–1586.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note